Concepedia

Pamela Foulds

PF

Statistics

Publications

6

Citations

386

H-Index

6

Active since

2010

Affiliations

Biogen (United States)(Current)

Cleveland Clinic

Aegerion Pharmaceuticals (United States)

Oregon Health & Science University

Pamela Foulds is an author at Biogen (United States) specializing in medicine, clinical pharmacology, and multiple sclerosis.

Top concepts

Publications per year

2010–2017

6

Publications

6

Predictors of long‐term outcome in multiple sclerosis patients treated with interferon beta

Robert Bermel, Xiaojun You, Pamela Foulds et al. · Annals of Neurology · 2012 · 176 citations

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study

R.A. Bermel, Bianca Weinstock‐Guttman, Dennis Bourdette et al. · Multiple Sclerosis Journal · 2010 · 75 citations

, , +15

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study

Karsten Beer, Martin J. Muller, Anna Marie Hew-Winzeler et al. · BMC Neurology · 2011 · 52 citations · Full text

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia

Mariko Harada‐Shiba, Katsunori Ikewaki, Atsushi Nohara et al. · Journal of Atherosclerosis and Thrombosis · 2017 · 51 citations · Full text

Change in quality of life in patients with relapsing–remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon β-1a

DM Miller, Bianca Weinstock‐Guttman, Dennis Bourdette et al. · Multiple Sclerosis Journal · 2011 · 22 citations

1–5 of 6